BROXYURIDINE

Broxyuridine is a thymidine analogue used in cancer research to study cell proliferation. Side effects in lab settings include cytotoxicity and irritation.

SKU: cbd4493ad555 Category: Tag:

Product Description


Mechanism of action

Broxyuridine (5‑bromoxyuridine, BrXU) is a halogenated uridine analogue incorporated into replicating DNA, disrupting base pairing and increasing DNA fragility. It is used as a thymidine substitute and acts as a radiosensitiser by enhancing DNA damage under ionising radiation.

Benefits and advantages

Critical in DNA‑replication studies, radiosensitisation research, mutagenesis assays, nucleotide‑analogue comparisons, cell‑cycle tracking and DNA‑repair pathway analysis.

Side effects and risks

Risks include mutagenicity, cytotoxicity, teratogenicity and photosensitivity. Handle under nucleoside‑analogue and radiomimetic‑compound containment procedures.

Datasheet


Molecular Formula

C9H11BrN2O5

Molecular Weight

307.10 g/mol

CAS Number

59-14-3

Storage Condition

Store solid BrdU and its solutions in dark-colored, tightly closed containers, preferably under refrigeration. Avoid exposure to light and moisture. Store working quantities of BrdU and its solutions in an explosion-safe refrigerator in the work area.

Solubility

10 to 50 mg/mL at 72 °F (NTP, 1992)

Purity

Purity information is available upon request (COA).

Synonym

5-BROMO-2'-DEOXYURIDINE; 59-14-3; Broxuridine; Bromodeoxyuridine; 5-Bromodeoxyuridine

IUPAC/Chemical Name

1-(2€‘bromo€‘3,4€‘dihydroxybutyl)uracil

InChl Key

OLWQDXLCSQKZLX-UHFFFAOYSA-N

InChl Code

InChI=1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1

References

https://pubchem.ncbi.nlm.nih.gov/#query=59-14-3;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download